Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds

NCT ID: NCT00407914

Last Updated: 2009-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

315 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-12-31

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effectiveness of Aquamid and Restylane in aesthetically enhancing nasolabial folds 6 months after treatment and to evaluate the safety of Aquamid through 12 months after treatment.

The study includes an extended follow up to 24 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Facial Wrinkles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Aquamid

Group Type EXPERIMENTAL

Aquamid

Intervention Type DEVICE

Subcutaneous injection

2

Restylane

Group Type ACTIVE_COMPARATOR

Restylane

Intervention Type DEVICE

Injection in dermis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aquamid

Subcutaneous injection

Intervention Type DEVICE

Restylane

Injection in dermis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* interested on soft tissue augmentation for the nasolabial folds
* moderate to severe nasolabial fold

Exclusion Criteria

* sensitivity to anesthetics
* allergy to hyaluronic acid
* previous treatment with permanent fillers in the treated area
* recent previous aesthetic procedure in the treatment area
* infected skin areas or autoimmune diseases affecting the skin
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Contura

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Contura

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Silvia Codony

Role: STUDY_DIRECTOR

Contura

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

White Plains, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

von Buelow S, von Heimburg D, Pallua N. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation. Plast Reconstr Surg. 2005 Sep 15;116(4):1137-46; discussion 1147-8. doi: 10.1097/01.prs.0000179349.14392.a4.

Reference Type BACKGROUND
PMID: 16163108 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CONAQ-US01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Performance of PTMC Dermal Filler
NCT06316479 NOT_YET_RECRUITING NA